GB0117144D0 - Process - Google Patents
ProcessInfo
- Publication number
- GB0117144D0 GB0117144D0 GB0117144A GB0117144A GB0117144D0 GB 0117144 D0 GB0117144 D0 GB 0117144D0 GB 0117144 A GB0117144 A GB 0117144A GB 0117144 A GB0117144 A GB 0117144A GB 0117144 D0 GB0117144 D0 GB 0117144D0
- Authority
- GB
- United Kingdom
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0117144A GB0117144D0 (en) | 2001-07-13 | 2001-07-13 | Process |
PCT/GB2002/003185 WO2003006462A1 (en) | 2001-07-13 | 2002-07-10 | Processes for the manufacture of thrombin inhibitors and n-pyridin-4-yl-oxazolidin-2-ones as intermediate therefor |
ARP020102596 AR034867A1 (en) | 2001-07-13 | 2002-07-11 | INTERMEDIARY PIRIDINE 4-SUBSTITUTE COMPOUND, PROCEDURE TO PREPARE IT, PROCEDURE TO PREPARE AN INTERMEDIATE PIRIDINE 4-ALKYLAMINE COMPOSITE AND PROCEDURE TO PREPARE A BENZAMIDA COMPOUND |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0117144A GB0117144D0 (en) | 2001-07-13 | 2001-07-13 | Process |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0117144D0 true GB0117144D0 (en) | 2001-09-05 |
Family
ID=9918463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0117144A Ceased GB0117144D0 (en) | 2001-07-13 | 2001-07-13 | Process |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR034867A1 (en) |
GB (1) | GB0117144D0 (en) |
WO (1) | WO2003006462A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL155447A0 (en) | 2000-10-20 | 2003-11-23 | Eisai Co Ltd | Nitrogenous aromatic ring compounds |
EP1683785B1 (en) | 2003-11-11 | 2013-10-16 | Eisai R&D Management Co., Ltd. | Urea derivative and process for producing the same |
US8772269B2 (en) | 2004-09-13 | 2014-07-08 | Eisai R&D Management Co., Ltd. | Use of sulfonamide-including compounds in combination with angiogenesis inhibitors |
WO2006030941A1 (en) | 2004-09-13 | 2006-03-23 | Eisai R & D Management Co., Ltd. | Simultaneous use of sulfonamide-containing compound and angiogenesis inhibitor |
AU2005283422C1 (en) | 2004-09-17 | 2017-02-02 | Eisai R & D Management Co., Ltd. | Medicinal composition |
EP2281901B1 (en) | 2005-08-02 | 2013-11-27 | Eisai R&D Management Co., Ltd. | Anti-tumour pharmaceutical composition with angiogenesis inhibitors |
US20090209580A1 (en) | 2006-05-18 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Antitumor agent for thyroid cancer |
JP5368096B2 (en) | 2006-08-28 | 2013-12-18 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Anti-tumor agent for undifferentiated gastric cancer |
WO2008093855A1 (en) | 2007-01-29 | 2008-08-07 | Eisai R & D Management Co., Ltd. | Composition for treatment of undifferentiated-type of gastric cancer |
KR101513326B1 (en) | 2007-11-09 | 2015-04-17 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Combination of anti-angiogenic substance and anti-tumor platinum complex |
ES2573515T3 (en) | 2010-06-25 | 2016-06-08 | Eisai R&D Management Co., Ltd. | Anti-tumor agent that uses compounds with combined kinase inhibitory effect |
CN103402519B (en) | 2011-04-18 | 2015-11-25 | 卫材R&D管理有限公司 | tumor therapeutic agent |
WO2012166899A2 (en) | 2011-06-03 | 2012-12-06 | Eisai R&D Management Co., Ltd. | Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds |
KR20150098605A (en) | 2012-12-21 | 2015-08-28 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Amorphous form of quinoline derivative, and method for producing same |
CA2912219C (en) | 2013-05-14 | 2021-11-16 | Eisai R&D Management Co., Ltd. | Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds |
KR102512940B1 (en) | 2014-08-28 | 2023-03-23 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | High-purity quinoline derivative and method for manufacturing same |
JP6792546B2 (en) | 2015-02-25 | 2020-11-25 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | How to suppress bitterness of quinoline derivatives |
WO2016140717A1 (en) | 2015-03-04 | 2016-09-09 | Merck Sharp & Dohme Corp. | Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer |
US11369623B2 (en) | 2015-06-16 | 2022-06-28 | Prism Pharma Co., Ltd. | Anticancer combination of a CBP/catenin inhibitor and an immune checkpoint inhibitor |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9525620D0 (en) * | 1995-12-15 | 1996-02-14 | Glaxo Group Ltd | Chemical compounds |
GB9821483D0 (en) * | 1998-10-03 | 1998-11-25 | Glaxo Group Ltd | Chemical compounds |
-
2001
- 2001-07-13 GB GB0117144A patent/GB0117144D0/en not_active Ceased
-
2002
- 2002-07-10 WO PCT/GB2002/003185 patent/WO2003006462A1/en not_active Application Discontinuation
- 2002-07-11 AR ARP020102596 patent/AR034867A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003006462A1 (en) | 2003-01-23 |
AR034867A1 (en) | 2004-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0111020D0 (en) | Process | |
GB0120835D0 (en) | Process | |
GB0109555D0 (en) | Process | |
GB0117144D0 (en) | Process | |
GB0113645D0 (en) | Process | |
GB0113789D0 (en) | Process | |
GB0117090D0 (en) | Process | |
GB0112792D0 (en) | Process | |
GB0127423D0 (en) | Process | |
GB0112801D0 (en) | Process | |
GB0116212D0 (en) | Process | |
GB0112331D0 (en) | Process | |
GB2393678B (en) | Cast-bonding process | |
GB0112789D0 (en) | Process | |
GB0126768D0 (en) | Novel process | |
GB0114033D0 (en) | Process | |
GB0113370D0 (en) | Process | |
GB0112327D0 (en) | Process | |
GB0113772D0 (en) | Process | |
GB0113922D0 (en) | Process | |
GB0112794D0 (en) | Process | |
GB0113640D0 (en) | Process | |
GB0113787D0 (en) | Process | |
GB0112787D0 (en) | Process | |
GB0113641D0 (en) | Process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |